Home LiteratureArticle Details
PMID: 19321746 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Mathas S, Kreher S, Meaburn KJ, Jöhrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dörken B

Abstract

Although the identification and characterization of translocations have rapidly increased, little is known about the mechanisms of how translocations occur in vivo. We used anaplastic large cell lymphoma (ALCL) with and without the characteristic t(2;5)(p23;q35) translocation to study the mechanisms of formation of translocations and of ALCL transformation. We report deregulation of several genes located near the ALCL translocation breakpoint, regardless of whether the tumor contains the t(2;5). The affected genes include the oncogenic transcription factor Fra2 (located on 2p23), the HLH protein Id2 (2p25), and the oncogenic tyrosine kinase CSF1-receptor (5q33.1). Their up-regulation promotes cell survival and repression of T cell-specific gene expression programs that are characteristic for ALCL. The deregulated genes are in spatial proximity within the nuclear space of t(2;5)-negative ALCL cells, facilitating their translocation on induction of double-strand breaks. These data suggest that deregulation of breakpoint-proximal genes occurs before the formation of translocations, and that aberrant transcriptional activity of genomic regions is linked to their propensity to undergo chromosomal translocations. Also, our data demonstrate that deregulation of breakpoint-proximal genes has a key role in ALCL.

MeSH Terms
Cell Line, Tumor Chromosome Breakage Chromosomes, Human, Pair 2 Chromosomes, Human, Pair 5 Fos-Related Antigen-2/genetics Gene Expression Regulation, Neoplastic Genome, Human Humans Inhibitor of Differentiation Protein 2/genetics Lymphoma, Large-Cell, Anaplastic/genetics,pathology Receptor, Macrophage Colony-Stimulating Factor/genetics Transcription, Genetic Translocation, Genetic
Chemicals
FOSL2 protein, human Fos-Related Antigen-2 ID2 protein, human Inhibitor of Differentiation Protein 2 Receptor, Macrophage Colony-Stimulating Factor
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Mathas Stephan
Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany. stephan.mathas@charite.de
Kreher Stephan
Meaburn Karen J
Jöhrens Korinna
Lamprecht Björn
Assaf Chalid
Sterry Wolfram
Kadin Marshall E
Daibata Masanori
Joos Stefan
Hummel Michael
Stein Harald
Janz Martin
Anagnostopoulos Ioannis
Schrock Evelin
Misteli Tom
Dörken Bernd
References (41)
41 references, click to expand
  1. Spatial genome organization in the formation of chromosomal translocations.
    Semin Cancer Biol. 2007 Feb;17(1):80-90 PMID: 17137790
  2. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
    Blood. 2000 Dec 1;96(12):3681-95 PMID: 11090048
  3. The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model.
    Oncogene. 2003 Jul 24;22(30):4642-7 PMID: 12879008
  4. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh.
    PLoS Biol. 2007 Aug;5(8):e192 PMID: 17622196
  5. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
    Oncogene. 2008 May 22;27(23):3221-32 PMID: 18071306
  6. Active genes dynamically colocalize to shared sites of ongoing transcription.
    Nat Genet. 2004 Oct;36(10):1065-71 PMID: 15361872
  7. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Nature. 1987 Feb 5-11;325(6104):549-52 PMID: 3027579
  8. The anaplastic lymphoma kinase in the pathogenesis of cancer.
    Nat Rev Cancer. 2008 Jan;8(1):11-23 PMID: 18097461
  9. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals.
    Genes Chromosomes Cancer. 2003 Mar;36(3):211-23 PMID: 12557221
  10. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
    Cancer Res. 2003 Mar 15;63(6):1179-82 PMID: 12649172
  11. An oncogene-induced DNA damage model for cancer development.
    Science. 2008 Mar 7;319(5868):1352-5 PMID: 18323444
  12. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
    Oncogene. 2001 Apr 30;20(19):2453-64 PMID: 11402340
  13. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
    Science. 2000 Oct 6;290(5489):138-41 PMID: 11021799
  14. Spatial proximity of translocation-prone gene loci in human lymphomas.
    Nat Genet. 2003 Jul;34(3):287-91 PMID: 12808455
  15. The impact of translocations and gene fusions on cancer causation.
    Nat Rev Cancer. 2007 Apr;7(4):233-45 PMID: 17361217
  16. B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
    Int J Cancer. 2006 Feb 1;118(3):688-95 PMID: 16114011
  17. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cancer. 2008 Feb 1;112(3):552-61 PMID: 18085637
  18. Id family of helix-loop-helix proteins in cancer.
    Nat Rev Cancer. 2005 Aug;5(8):603-14 PMID: 16034366
  19. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.
    J Biol Chem. 1999 Feb 19;274(8):4939-46 PMID: 9988737
  20. Locus-specific and activity-independent gene repositioning during early tumorigenesis.
    J Cell Biol. 2008 Jan 14;180(1):39-50 PMID: 18195100
  21. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
    Cell. 2004 Oct 29;119(3):431-43 PMID: 15507213
  22. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Blood. 2006 Mar 15;107(6):2536-9 PMID: 16263788
  23. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes.
    Mol Cell Biol. 1990 Jun;10(6):2703-14 PMID: 2160584
  24. Launching the T-cell-lineage developmental programme.
    Nat Rev Immunol. 2008 Jan;8(1):9-21 PMID: 18097446
  25. Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.
    Blood. 1998 Jun 15;91(12):4668-76 PMID: 9616164
  26. Promoter specificity and biological activity of tethered AP-1 dimers.
    Mol Cell Biol. 2002 Jul;22(13):4952-64 PMID: 12052899
  27. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.
    Blood. 2003 Feb 15;101(4):1513-9 PMID: 12393503
  28. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation.
    Blood. 1999 Feb 15;93(4):1197-207 PMID: 9949162
  29. Increased recombination between active tRNA genes.
    DNA Cell Biol. 2006 Jun;25(6):359-64 PMID: 16792506
  30. Positional stability of single double-strand breaks in mammalian cells.
    Nat Cell Biol. 2007 Jun;9(6):675-82 PMID: 17486118
  31. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
    Nat Immunol. 2006 Feb;7(2):207-15 PMID: 16369535
  32. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.
    EMBO J. 2002 Aug 1;21(15):4104-13 PMID: 12145210
  33. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.
    Mol Cell Biol. 1997 Aug;17(8):4782-91 PMID: 9234734
  34. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.
    Blood. 2004 Nov 15;104(10):3358-60 PMID: 15297316
  35. WHO-EORTC classification for cutaneous lymphomas.
    Blood. 2005 May 15;105(10):3768-85 PMID: 15692063
  36. Functional organisation of the genome during interphase.
    Curr Opin Genet Dev. 2007 Oct;17(5):451-5 PMID: 17920259
  37. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
    Blood. 2005 Dec 15;106(13):4287-93 PMID: 16123212
  38. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
    Cancer Res. 1999 Nov 1;59(21):5578-85 PMID: 10554038
  39. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
    Br J Haematol. 2007 May;137(4):342-8 PMID: 17456056
  40. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains.
    Science. 2004 Jan 2;303(5654):92-5 PMID: 14704429
  41. Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation.
    Pediatr Dermatol. 2004 May-Jun;21(3):212-7 PMID: 15165197
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2009-04-07
Epub
2009-00-25
Pages
5831-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2667034
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com